Track topics on Twitter Track topics that are important to you
The Wall Street Journal reports that Mylan remains in a leading position in the U.S. market for emergency allergy medications despite the higher cost of its EpiPen , commanding a market share of more than 25%. The company has been able to hold onto a healthy share of the business despite non-branded/competitive alternatives through its contracts with pharmacy benefit managers like Express Scripts and CVS Health, who prioritize EpiPen because the margins are better.NEXT ARTICLE
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...